According to Armata Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | -1.50 | -58.99% |
2023-12-31 | -3.65 | -394.02% |
2022-12-31 | 1.24 | -78.77% |
2021-12-31 | 5.85 | 97.76% |
2020-12-31 | 2.96 | 33.86% |
2019-12-31 | 2.21 | 181.09% |
2018-12-31 | 0.7862 | -36.65% |
2017-12-31 | 1.24 | 146.6% |
2016-12-31 | 0.5032 | -72.68% |
2015-12-31 | 1.84 | -84.5% |
2014-12-31 | 11.9 | |
2013-12-31 | N/A | |
2009-12-31 | N/A | |
2008-12-31 | N/A | |
2007-12-31 | N/A | |
2006-12-31 | N/A | |
2005-12-31 | N/A | |
2004-12-31 | N/A | |
2003-12-31 | N/A | |
2002-12-31 | N/A |